US Stock MarketDetailed Quotes

AVNS Avanos Medical

Watchlist
  • 16.080
  • -0.460-2.78%
Close Dec 20 16:00 ET
  • 16.080
  • 0.0000.00%
Post 16:15 ET
738.99MMarket Cap47.29P/E (TTM)

Avanos Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-0.53%170.4M
1.36%171.7M
4.27%166.1M
-1.58%673.3M
-4.57%173.3M
-0.58%171.3M
-0.88%169.4M
-19.30%159.3M
16.54%684.1M
407.26%181.6M
Operating revenue
-0.53%170.4M
1.36%171.7M
4.27%166.1M
-1.58%673.3M
-4.57%173.3M
-0.58%171.3M
-0.88%169.4M
-19.30%159.3M
16.54%684.1M
407.26%181.6M
Cost of revenue
2.24%77.5M
6.28%76.1M
5.01%71.3M
1.28%293.6M
-0.51%78.3M
5.13%75.8M
3.32%71.6M
-25.22%67.9M
0.73%289.9M
2,148.57%78.7M
Gross profit
-2.72%92.9M
-2.25%95.6M
3.72%94.8M
-3.68%379.7M
-7.68%95M
-4.69%95.5M
-3.74%97.8M
-14.26%91.4M
31.75%394.2M
218.58%102.9M
Operating expense
-14.21%80.9M
-10.61%89.3M
-6.87%90.8M
4.68%375.5M
-2.90%83.8M
7.89%94.3M
9.18%99.9M
-0.51%97.5M
6.06%358.7M
57.77%86.3M
Selling and administrative expenses
-5.59%74.3M
-13.01%80.9M
-5.86%83.6M
2.60%335M
-5.34%74.5M
0.51%78.7M
11.78%93M
-1.44%88.8M
14.44%326.5M
30.73%78.7M
Research and development costs
18.03%7.2M
-7.35%6.3M
-6.67%7M
-6.85%27.2M
-5.56%6.8M
-14.08%6.1M
-10.53%6.8M
-3.85%7.5M
-4.58%29.2M
22.03%7.2M
Other operating expenses
-106.32%-600K
2,000.00%2.1M
-83.33%200K
343.33%13.3M
525.00%2.5M
375.00%9.5M
-85.71%100K
1,100.00%1.2M
-86.55%3M
103.51%400K
Operating profit
900.00%12M
400.00%6.3M
165.57%4M
-88.17%4.2M
-32.53%11.2M
-90.63%1.2M
-120.79%-2.1M
-170.93%-6.1M
191.03%35.5M
174.11%16.6M
Net non-operating interest income expense
34.21%-2.5M
96.67%-100K
16.67%-2.5M
-37.50%-12.1M
0.00%-2.3M
-40.74%-3.8M
-20.00%-3M
-130.77%-3M
-183.87%-8.8M
-228.57%-2.3M
Non-operating interest income
-22.22%700K
500.00%3M
20.00%600K
141.67%2.9M
42.86%1M
200.00%900K
150.00%500K
--500K
500.00%1.2M
--700K
Non-operating interest expense
-31.91%3.2M
-11.43%3.1M
-11.43%3.1M
50.00%15M
10.00%3.3M
56.67%4.7M
29.63%3.5M
169.23%3.5M
203.03%10M
328.57%3M
Other net income (expense)
Income before tax
465.38%9.5M
221.57%6.2M
116.48%1.5M
-129.59%-7.9M
-37.76%8.9M
-125.74%-2.6M
-167.11%-5.1M
-224.66%-9.1M
163.42%26.7M
161.90%14.3M
Income tax
-41.94%3.6M
337.50%1.9M
176.92%1M
-61.54%2M
-145.65%-2.1M
788.89%6.2M
-128.57%-800K
-168.42%-1.3M
146.43%5.2M
76.92%4.6M
Net income
216.22%4.3M
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
Net income continuous Operations
167.05%5.9M
200.00%4.3M
106.41%500K
-146.05%-9.9M
13.40%11M
-180.00%-8.8M
-189.58%-4.3M
-244.44%-7.8M
169.58%21.5M
137.74%9.7M
Net income discontinuous operations
-131.37%-1.6M
96.08%-2.5M
-119.18%-1.4M
-278.97%-51.9M
-106.94%-500K
8.51%5.1M
-928.57%-63.8M
--7.3M
-22.04%29M
--7.2M
Minority interest income
Net income attributable to the parent company
216.22%4.3M
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
216.22%4.3M
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
Basic earnings per share
225.00%0.1
102.74%0.04
-100.00%-0.02
-222.22%-1.32
-36.11%0.23
-123.53%-0.08
-640.74%-1.46
-109.09%-0.01
730.77%1.08
71.43%0.36
Diluted earnings per share
212.50%0.09
102.74%0.04
-100.00%-0.02
-223.36%-1.32
-36.11%0.23
-124.24%-0.08
-661.54%-1.46
-109.09%-0.01
723.08%1.07
71.43%0.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -0.53%170.4M1.36%171.7M4.27%166.1M-1.58%673.3M-4.57%173.3M-0.58%171.3M-0.88%169.4M-19.30%159.3M16.54%684.1M407.26%181.6M
Operating revenue -0.53%170.4M1.36%171.7M4.27%166.1M-1.58%673.3M-4.57%173.3M-0.58%171.3M-0.88%169.4M-19.30%159.3M16.54%684.1M407.26%181.6M
Cost of revenue 2.24%77.5M6.28%76.1M5.01%71.3M1.28%293.6M-0.51%78.3M5.13%75.8M3.32%71.6M-25.22%67.9M0.73%289.9M2,148.57%78.7M
Gross profit -2.72%92.9M-2.25%95.6M3.72%94.8M-3.68%379.7M-7.68%95M-4.69%95.5M-3.74%97.8M-14.26%91.4M31.75%394.2M218.58%102.9M
Operating expense -14.21%80.9M-10.61%89.3M-6.87%90.8M4.68%375.5M-2.90%83.8M7.89%94.3M9.18%99.9M-0.51%97.5M6.06%358.7M57.77%86.3M
Selling and administrative expenses -5.59%74.3M-13.01%80.9M-5.86%83.6M2.60%335M-5.34%74.5M0.51%78.7M11.78%93M-1.44%88.8M14.44%326.5M30.73%78.7M
Research and development costs 18.03%7.2M-7.35%6.3M-6.67%7M-6.85%27.2M-5.56%6.8M-14.08%6.1M-10.53%6.8M-3.85%7.5M-4.58%29.2M22.03%7.2M
Other operating expenses -106.32%-600K2,000.00%2.1M-83.33%200K343.33%13.3M525.00%2.5M375.00%9.5M-85.71%100K1,100.00%1.2M-86.55%3M103.51%400K
Operating profit 900.00%12M400.00%6.3M165.57%4M-88.17%4.2M-32.53%11.2M-90.63%1.2M-120.79%-2.1M-170.93%-6.1M191.03%35.5M174.11%16.6M
Net non-operating interest income expense 34.21%-2.5M96.67%-100K16.67%-2.5M-37.50%-12.1M0.00%-2.3M-40.74%-3.8M-20.00%-3M-130.77%-3M-183.87%-8.8M-228.57%-2.3M
Non-operating interest income -22.22%700K500.00%3M20.00%600K141.67%2.9M42.86%1M200.00%900K150.00%500K--500K500.00%1.2M--700K
Non-operating interest expense -31.91%3.2M-11.43%3.1M-11.43%3.1M50.00%15M10.00%3.3M56.67%4.7M29.63%3.5M169.23%3.5M203.03%10M328.57%3M
Other net income (expense)
Income before tax 465.38%9.5M221.57%6.2M116.48%1.5M-129.59%-7.9M-37.76%8.9M-125.74%-2.6M-167.11%-5.1M-224.66%-9.1M163.42%26.7M161.90%14.3M
Income tax -41.94%3.6M337.50%1.9M176.92%1M-61.54%2M-145.65%-2.1M788.89%6.2M-128.57%-800K-168.42%-1.3M146.43%5.2M76.92%4.6M
Net income 216.22%4.3M102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M
Net income continuous Operations 167.05%5.9M200.00%4.3M106.41%500K-146.05%-9.9M13.40%11M-180.00%-8.8M-189.58%-4.3M-244.44%-7.8M169.58%21.5M137.74%9.7M
Net income discontinuous operations -131.37%-1.6M96.08%-2.5M-119.18%-1.4M-278.97%-51.9M-106.94%-500K8.51%5.1M-928.57%-63.8M--7.3M-22.04%29M--7.2M
Minority interest income
Net income attributable to the parent company 216.22%4.3M102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 216.22%4.3M102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M
Basic earnings per share 225.00%0.1102.74%0.04-100.00%-0.02-222.22%-1.32-36.11%0.23-123.53%-0.08-640.74%-1.46-109.09%-0.01730.77%1.0871.43%0.36
Diluted earnings per share 212.50%0.09102.74%0.04-100.00%-0.02-223.36%-1.32-36.11%0.23-124.24%-0.08-661.54%-1.46-109.09%-0.01723.08%1.0771.43%0.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data